Logo

Crossref


1. A Qualitative Study of the Relationship Between Methamphetamine Abuse and Sexual Dysfunction in Male Substance Abusers

- Behrouz Dolatshahi

- Ali Farhoudian

- Mozhgan Falahatdoost

- Mahmoud Tavakoli

- Ebrahim Rezaie Dogahe

2. Modafinil for the Treatment of Methamphetamine Dependence

- Maryam Lashkaripour

- Amir Adibi

- Farzaneh Farajian Mashhadi

- Alireza Dashipour

3. Methamphetamine use and treatment in Iran: A systematic review from the most populated Persian Gulf country

- Zahra Alam-mehrjerdi

- Azarakhsh Mokri

- Kate Dolan

4. The Persian methamphetamine use in methadone treatment in Iran: implication for prevention and treatment in an upper-middle income country

- Zahra Alam-mehrjerdi

- Mohammad Abdollahi

5. Methamphetamine Use Disorder Untreated among Women in Methadone Treatment in Iran

- Zahra Alammehrjerdi

- Nadine Ezard

- Philip Clare

- Kate Dolan

6. Amphetamine-Type Stimulants in a Group of Adults in Tehran, Iran: A Rapid Situation Assessment in Twenty-Two Districts

- Roya Noori

- Reza Daneshmand

- Ali Farhoudian

- Salahedin Ghaderi

- Sepideh Aryanfard

- Afsaneh Moradi

7. Crystal in Iran: methamphetamine or heroin kerack

- Zahra Alam Mehrjerdi

8. Comparison of Characteristics of Methamphetamine Versus Opiate Users in Tehran, Iran

- Roya Noori

- Ali Farhoudian

- Hooman Naranjiha

- Mohammad Hassan Farhadi

- Kate Dolan

- Hamid-Reza Khoddami-Vishteh

9. Methamphetamine Use Disorder Untreated among Women in Methadone Treatment in Iran

- Zahra Alammehrjerdi

- Nadine Ezard

- Philip Clare

- Kate Dolan

10. Crystal methamphetamine use and its correlates in women engaged in sex work in a developing country setting

- Mostafa Shokoohi

- Mohammad Karamouzian

- Hamid Sharifi

- Afarin Rahimi-Movaghar

- Adam W. Carrico

- Samira Hosseini Hooshyar

- Ali Mirzazadeh

11. Methamphetamine dependence in methadone treatment services in Iran: the first literature review of a new health concern

- Zahra Alammehrjerdi

- Nadine Ezard

- Kate Dolan

12. Predictors of time to relapse in amphetamine-type substance users in the matrix treatment program in Iran: a Cox proportional hazard model application

- Maryam Moeeni

- Emran M. Razaghi

- Koen Ponnet

- Fatemeh Torabi

- Seyed Ali Shafiee

- Tahereh Pashaei

13. No evidence of subgroups found in amphetamine consumers in Iran

- Atireza Bananej

- Sabine Völkl-Kernstock

- Otto Lesch

- Henriette Walter

- Katrin Skala